FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/10/095571 [Registered on: 03/10/2025] Trial Registered Prospectively
Last Modified On: 01/10/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Single Arm Study 
Public Title of Study   Effect of Rohitakabhaya kwatha in management of Non alcoholic fatty liver disease. 
Scientific Title of Study   “CLINICAL EVALUATION OF ROHITAKABHAYA KWATHA IN NON-ALCOHOLIC FATTY LIVER DISEASE” 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Charu Sharma 
Designation  Professor 
Affiliation  Quadra Institute of Ayurveda and Hospital Roorkee Haridwar 
Address  Opd No 3 Department of Kayachikitsa Quadra Institute of Ayurveda and Hospital NH 58 Roorkee Haridwar Road Near Montfort School Roorkee Haridwar 247667

Hardwar
UTTARANCHAL
247667
India 
Phone  7060398172  
Fax    
Email  charu22jan@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Charu Sharma 
Designation  Professor 
Affiliation  Quadra Institute of Ayurveda and Hospital Roorkee Haridwar 
Address  Opd No 3 Department of Kayachikitsa Quadra Institute of Ayurveda and Hospital NH 58 Roorkee Haridwar Road Near Montfort School Roorkee Haridwar 247667


UTTARANCHAL
247667
India 
Phone  7060398172  
Fax    
Email  charu22jan@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Nancy 
Designation  PG Scholar 
Affiliation  Quadra Institute of Ayurveda and Hospital Roorkee Haridwar 
Address  Opd No 3 Department of Kayachikitsa Quadra Institute of Ayurveda and Hospital NH 58 Roorkee Haridwar Road Near Montfort School Roorkee Haridwar 247667

Hardwar
UTTARANCHAL
247667
India 
Phone  9313303417  
Fax    
Email  nancypanjeta07@gmail.com  
 
Source of Monetary or Material Support  
Nancy Opd No 3 Department of Kayachikitsa Quadra Institute of Ayurveda and Hospital NH 58 Roorkee Haridwar Road Near Montfort School Roorkee Haridwar(India) 247667 
 
Primary Sponsor  
Name  Nancy 
Address  Opd No 3 Department of Kayachikitsa Quadra Institute of Ayurveda and Hospital NH 58 Roorkee Haridwar Road Near Montfort School Roorkee Haridwar(India) 247667 
Type of Sponsor  Other [[Self]] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Nancy  Quadra Institute of Ayurveda and Hospital   Opd No 3 Department of Kayachikitsa Quadra Institute of Ayurveda and Hospital NH 58 Roorkee Haridwar Road Near Montfort School Roorkee Haridwar 247667
Hardwar
UTTARANCHAL 
9313303417

nancypanjeta07@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Committee Quadra Institute of Ayurveda  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:K760||Fatty (change of) liver, not elsewhere classified. Ayurveda Condition: YAKRU,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Rohitakabhaya kwatha, Reference: Chakradatta 38/4, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 40(ml), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 45 Days, anupAna/sahapAna: Yes(details: -Lukewarm water), Additional Information: -
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1. Patient having ultrasonographical evidence of NAFLD and BMI (25-40 Kg/m2).
2. Patient’s having altered serum liver enzymes levels defined as serum ALT and AST more than normal (>40 IU/L) but less than two times of the upper limit of the normal value(<80 IU/L).
3. Subjects of either sex, age group 20-60 years who are non-alcoholics or they have history of alcohol intake less than 20 g/day.
 
 
ExclusionCriteria 
Details  1. Patients who is unwilling to participate in study.
2. Patients having serum liver enzymes AST and ALT more than 2 times of upper normal limit.(i.e.AST more than 76 U/L; ALT more than 82 U/L)
3. Patients having ultrasonographical evidence of cirrhosis or necrosis of liver.
4. Patient who is consuming alcohol.
5. Patient testing positive for hepatitis B & hepatitis C, uncontrolled diabetes, malignancy of liver or having any other comorbidity.
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Relief in subjective parameters:
1.Utklesha
2. Chardi
3. Aruchi
4. Hridkantadaha
5. Udarashoola 
First assessment 15 days post- treatment initiation.
Second Assessment- 15 days after the first assessment.
Third Assessment- 15 days after the second assessment.
 
 
Secondary Outcome  
Outcome  TimePoints 
Relief in objective parameters:
1. Anthropometric measurements - Body weight, BMI
2. Biochemical tests - FBS, ALT, AST, GGT, AST/ALT Ratio, Alkaline phosphatase
3. Lipid profile - Serum cholesterol, Triglycerides, LDL, HDL, VLDL
4. Radiological - USG Whole Abdomen
 
Assessment will be done on day 0 and 45 day 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   13/10/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This is an open label  clinical study to evaluate Rohitakabhaya kwatha in Non Alcoholic fatty liver disease. It will be a clinical study of 30 patients suffering from Non alcoholic fatty liver disease. Patient will be selected randomly irrespective of their gender, race, religion, occupation. Patients with classical features of Yakritdalyodara attending the OPD/IPD of Kayachikitsa Department of Quadra Institute of Ayurveda and Hospital, Roorkee will be selected for this clinical study. The patients between the age group of 20-60 years of age will be selected. The assessment of the trial will be done on the basis of subjective and objective parameters. The period of study is 18 months and duration of study is 2 months. Data depending upon above subjective and objective criteria and other variables will be collected and analysed statistically. 
Close